About Us
Mission
Provide solutions to pioneer excellence in gene editing analysis
Vision
Empower innovation with integrity and collaboration
Core Values
Stay commited to collaboration, innovation and integrity
Why Countagen and Why Now?
Gene editing has opened many opportunities to transform research, drug development and personalized medicine. The real power of gene editing is being able to choose exactly where to edit a gene. Measuring the efficiency and specificity of gene editing is a critical step to ensure success and advance to practical applications. A typical gene editing workflow requires the assessment of different conditions before moving to functional assays. Methods used routinely to achieve this are multimodal and often require long time and different resources for optimization and data analysis. At Countagen, we are committed to accelerating this process by providing complete solutions that ensure swift and reliable quantification of gene editing efficiency.
The Team Origins
Countagen is a spin-off company from Mats Nilsson’s Lab at Stockholm University & Science for Life Laboratory in Sweden. We are committed to providing solutions to pioneer excellence in gene editing analysis. Our team gathers 20+ years of cutting-edge innovation in molecular analysis tools and a successful entrepreneurship trajectory.
We stay committed to moving beyond traditional CRISPR analysis methods and exploring novel approaches beyond the PCR regime. 🔨 This shift is reflected in our approach, marking the end of an old regime and embracing a dawn of innovative possibilities. 🌅
The Team
Felix Neumann
CEO
PhD in Biochemistry
Iván Hernández-Neuta
CSO
PhD in Biochemistry
Leiore Ajuria
Product Manager
PhD in Genetics
Trixy Fang
Senior Scientist
PhD in Biochemistry
Joost Bergman
Product Engineer
MSc in Biomedicine
Allison Whalen
Senior Field Application Specialist
Biotech Professional
Sonja Klose
Research Associate
MSc in Medical Biotechnology
Evelyn Lim
Marketing & BD Intern
BEng in Biomedical Engineering
Board of Directors
Mårten Winge
Chairman of the Board
Serial Entrepreneur and CEO at Strike Pharma
Stina Wallmark
Board Member
Investment Manager at Almi Invest and Board professional
Jon-Sverre Schanche
Board Member
Board professional and Life Science Research, Technology and Product Development advisor
Mats Nilsson
Board Member
Professor in Biochemistry at Stockholm University and Serial Entrepreneur
Scientific Advisors
Mats Nilsson
Board Member
Professor in Biochemistry at Stockholm University and Serial Entrepreneur
Bernhard Schmierer
Scientific Advisor
Head at the CRISPR Functional Genomics unit at Karolinska Institute
Sören Turan
Scientific Advisor
Scientist at Bayer Pharmaceuticals
Partners & Supporters